GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Cryosite Ltd (ASX:CTE) » Definitions » ROE % Adjusted to Book Value

Cryosite (ASX:CTE) ROE % Adjusted to Book Value : 3.86% (As of Dec. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Cryosite ROE % Adjusted to Book Value?

Cryosite's ROE % for the quarter that ended in Dec. 2024 was 121.45%. Cryosite's PB Ratio for the quarter that ended in Dec. 2024 was 31.48. Cryosite's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was 3.86%.


Cryosite ROE % Adjusted to Book Value Historical Data

The historical data trend for Cryosite's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryosite ROE % Adjusted to Book Value Chart

Cryosite Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only Negative Equity 28.70 7.35 5.54 2.10

Cryosite Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.99 5.51 5.81 2.21 3.86

Competitive Comparison of Cryosite's ROE % Adjusted to Book Value

For the Diagnostics & Research subindustry, Cryosite's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cryosite's ROE % Adjusted to Book Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Cryosite's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Cryosite's ROE % Adjusted to Book Value falls into.


;
;

Cryosite ROE % Adjusted to Book Value Calculation

Cryosite's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=86.98% / 41.33
=2.10%

Cryosite's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=121.45% / 31.48
=3.86%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cryosite ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Cryosite's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Cryosite Business Description

Traded in Other Exchanges
N/A
Address
13a Ferndell Street, South Granville, Sydney, NSW, AUS, 2142
Cryosite Ltd is engaged in the provision of supply chain logistics, and management of pharmaceutical products used in clinical trials. The company's operating segment includes Cord Blood and Tissue Storage and Clinical Trials and Biological Services Logistics. It generates maximum revenue from the Clinical Trials and Biological Services Logistics segment. The clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labeling, status management, secondary packaging, scheduled drug distribution, destruction, returns, and biological services.

Cryosite Headlines

No Headlines